JonathanALeffMD
Pulmonology • Menlo Park, CACritical Care Medicine
Executive Partner, Sofinnova Investments
Dr. Leff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
178 Seminary Dr
Menlo Park, CA 94025Phone+1 650-521-0353
Education & Training
University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1987 - 1990- University of ColoradoResidency, Internal Medicine, 1984 - 1987
Perelman School of Medicine at the University of PennsylvaniaClass of 1984
Certifications & Licensure
CA State Medical License 2003 - 2024
NJ State Medical License 1994 - 2003
CO State Medical License 1985 - 2001- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 310 citationsPirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trialsPaul W. Noble, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Roland M. du Bois
The European Respiratory Journal. 2016-01-01 - 83 citationsComprehensive assessment of the long‐term safety of pirfenidone in patients with idiopathic pulmonary fibrosisDominique Valeyre, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Talmadge E. King
Respirology. 2014-07-01 - 161 citations6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis.Roland M. du Bois, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Jonathan A. Leff
The European Respiratory Journal. 2014-05-01
Press Mentions
Up and down the Ladder: The Latest Comings and GoingsFebruary 26th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
